257 related articles for article (PubMed ID: 27756693)
1. It's all in the type of the task: Dopamine modulates kinematic patterns during competitive vs. cooperative interaction in Parkinson's disease.
Straulino E; Scaravilli T; Bulgheroni M; D'Amico E; Castiello U
Neuropsychologia; 2016 Dec; 93(Pt A):106-115. PubMed ID: 27756693
[TBL] [Abstract][Full Text] [Related]
2. Dopamine depletion affects communicative intentionality in Parkinson's disease patients: Evidence from action kinematics.
Straulino E; Scaravilli T; Castiello U
Cortex; 2016 Apr; 77():84-94. PubMed ID: 26922506
[TBL] [Abstract][Full Text] [Related]
3. Social intentions in Parkinson's disease patients: A kinematic study.
Straulino E; Scaravilli T; Castiello U
Cortex; 2015 Sep; 70():179-88. PubMed ID: 25804938
[TBL] [Abstract][Full Text] [Related]
4. The role of dopamine in cognitive sequence learning: evidence from Parkinson's disease.
Shohamy D; Myers CE; Grossman S; Sage J; Gluck MA
Behav Brain Res; 2005 Jan; 156(2):191-9. PubMed ID: 15582105
[TBL] [Abstract][Full Text] [Related]
5. Different action patterns for cooperative and competitive behaviour.
Georgiou I; Becchio C; Glover S; Castiello U
Cognition; 2007 Mar; 102(3):415-33. PubMed ID: 16516188
[TBL] [Abstract][Full Text] [Related]
6. Levodopa medication improves incidental sequence learning in Parkinson's disease.
Beigi M; Wilkinson L; Gobet F; Parton A; Jahanshahi M
Neuropsychologia; 2016 Dec; 93(Pt A):53-60. PubMed ID: 27686948
[TBL] [Abstract][Full Text] [Related]
7. The reach-to-grasp movement in Parkinson's disease before and after dopaminergic medication.
Castiello U; Bennett KM; Bonfiglioli C; Peppard RF
Neuropsychologia; 2000; 38(1):46-59. PubMed ID: 10617291
[TBL] [Abstract][Full Text] [Related]
8. Dopamine supports sentence comprehension in Parkinson's Disease.
Grossman M; Glosser G; Kalmanson J; Morris J; Stern MB; Hurtig HI
J Neurol Sci; 2001 Mar; 184(2):123-30. PubMed ID: 11239945
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET.
Cools R; Stefanova E; Barker RA; Robbins TW; Owen AM
Brain; 2002 Mar; 125(Pt 3):584-94. PubMed ID: 11872615
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease.
Lewis SJ; Slabosz A; Robbins TW; Barker RA; Owen AM
Neuropsychologia; 2005; 43(6):823-32. PubMed ID: 15716155
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease.
Cools R
Neurosci Biobehav Rev; 2006; 30(1):1-23. PubMed ID: 15935475
[TBL] [Abstract][Full Text] [Related]
12. Basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in Parkinson's disease.
Jones CR; Malone TJ; Dirnberger G; Edwards M; Jahanshahi M
Brain Cogn; 2008 Oct; 68(1):30-41. PubMed ID: 18378374
[TBL] [Abstract][Full Text] [Related]
13. l-DOPA changes ventral striatum recruitment during motor sequence learning in Parkinson's disease.
Kwak Y; Müller ML; Bohnen NI; Dayalu P; Seidler RD
Behav Brain Res; 2012 Apr; 230(1):116-24. PubMed ID: 22343069
[TBL] [Abstract][Full Text] [Related]
14. The function of dopaminergic neural signal transmission in auditory pulse perception: evidence from dopaminergic treatment in Parkinson's patients.
Geiser E; Kaelin-Lang A
Behav Brain Res; 2011 Nov; 225(1):270-5. PubMed ID: 21787806
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease.
Jahanshahi M; Jones CR; Zijlmans J; Katzenschlager R; Lee L; Quinn N; Frith CD; Lees AJ
Brain; 2010 Mar; 133(Pt 3):727-45. PubMed ID: 20305278
[TBL] [Abstract][Full Text] [Related]
16. Dopamine asymmetry interacts with medication to affect cognition in Parkinson's disease.
Tomer R; Aharon-Peretz J; Tsitrinbaum Z
Neuropsychologia; 2007 Jan; 45(2):357-67. PubMed ID: 16876208
[TBL] [Abstract][Full Text] [Related]
17. Motor loop dysfunction causes impaired cognitive sequencing in patients suffering from Parkinson's disease.
Schönberger AR; Hagelweide K; Pelzer EA; Fink GR; Schubotz RI
Neuropsychologia; 2015 Oct; 77():409-20. PubMed ID: 26382750
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the acute contributions of dopaminergic replacement to gait with obstacles in Parkinson's disease.
Pieruccini-Faria F; Vitório R; Almeida QJ; Silveira CR; Caetano MJ; Stella F; Gobbi S; Gobbi LT
J Mot Behav; 2013; 45(5):369-80. PubMed ID: 23834709
[TBL] [Abstract][Full Text] [Related]
19. Pre- and unplanned walking turns in Parkinson's disease - Effects of dopaminergic medication.
Conradsson D; Paquette C; Lökk J; Franzén E
Neuroscience; 2017 Jan; 341():18-26. PubMed ID: 27867059
[TBL] [Abstract][Full Text] [Related]
20. Task-dependent interactions between dopamine D2 receptor polymorphisms and L-DOPA in patients with Parkinson's disease.
Kwak Y; Bohnen NI; Müller ML; Dayalu P; Burke DT; Seidler RD
Behav Brain Res; 2013 May; 245():128-36. PubMed ID: 23439215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
